323818
Assessing the role of development assistance for health in improving child health in Rwanda
Rwanda has been benefiting from heavy foreign aid in financing its health sector and has seen one of the biggest falls in under-five mortality ever recorded. The mechanism of how foreign aid contributed to the country’s success in child mortality reduction is poorly understood. We propose an analytical framework to test a hypothesis that the level of health aid integration in to public health systems has a positive effect on child care financing, provision, utilization, and health outcomes.
Data and Methods
The study has two specific aims. Specific Aim 1 is to define and develop a metric to measure the level of aid integration into Rwanda’s public health systems. Data are from the Rwanda National Health Accounts, and Rwanda Health Resource Tracker. Specific Aim 2 is to understand health aid’s role in service provision at the health facility level, under-five children’s medical care utilization and their likelihood of being stunted at the individual level. A multivariate and multilevel model is used in analysis with the data from the District Health System Strengthening Tool and Rwanda Demographic and Health Surveys.
Results
Preliminary results show that health aid has been substantially integrated in the public health sector in Rwanda and made important contribution to financing provision of child medical care in rural health centers.
Recommendations
Learning Areas:
Public health or related public policyPublic health or related research
Learning Objectives:
Define health aid integration into public health systems
Assess the association between health aid and child health outcomes
Keyword(s): Child Health, International Health
Qualified on the content I am responsible for because: I made substantial contribution to the research.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.